Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can the adjusted mean SLEDAI-2K predict organ damage and coronary artery disease?

Nature Clinical Practice Rheumatology volume 2, pages 10–11 (2006)Cite this article

boxed-textIbanéz et al. (2005) Adjusted mean systemic lupus erythematosus disease activity index-2K is a predictor of outcome in SLE. J Rheumatol 32: 824–827

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research Guidance for Industry (online March 2005) Draft Guidance: Guidance for Industry. Systemic Lupus Erythematosus—Developing Drugs for Treatment [http://www.fda.gov/cder/guidance/6496dft.htm] (accessed March 2005)

  2. The American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria (2004) The American College of Rheumatology response criteria for Systemic Lupus Erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 50: 3418–3426

  3. Liang MH Translating outcomes measurement in experimental therapeutics of systemic rheumatic disease to patient care. Clinics in Rheumatic Disease, in press

  4. Tufte ER (2001) The Visual Display of Quantitative Information, edn 2. Cheshire: Graphics Press

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine at the Harvard Medical School, Boston, MA, USA

    Matthew H Liang

Authors
  1. Matthew H Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew H Liang.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, M. Can the adjusted mean SLEDAI-2K predict organ damage and coronary artery disease?. Nat Rev Rheumatol 2, 10–11 (2006). https://doi.org/10.1038/ncprheum0071

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0071

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing